Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
260 people die each day from dirty hands and dirty instruments! The Centers for Disease Control and Prevention in Atlanta, and the health care industry’s own monitoring agencies,…
260 people die each day from dirty hands and dirty instruments! The Centers for Disease Control and Prevention in Atlanta, and the health care industry’s own monitoring agencies,…
260 people die each day from dirty hands and dirty instruments! The Centers for Disease Control and Prevention in Atlanta, and the health care industry’s own monitoring agencies,…
260 people die each day from dirty hands and dirty instruments! The Centers for Disease Control and Prevention in Atlanta, and the health care industry’s own monitoring agencies,…
260 people die each day from dirty hands and dirty instruments! The Centers for Disease Control and Prevention in Atlanta, and the health care industry’s own monitoring agencies,…
NEW YORK (Reuters Health) – Basic clinical information can identify individuals at high risk of developing diabetes within 10 years, and adding some lab values identifies those at…
NEW YORK (Reuters Health) – Combining hepatic artery infusion of floxuridine/dexamethasone with systemic oxaliplatin and irinotecan can make liver metastases from colorectal cancer resectable in about half of…
NEW YORK (Reuters Health) – In patients with severe sepsis, early rather than later treatment with drotrecogin alfa (activated), in conjunction with other recommended therapies, may improve survival,…
NEW YORK (Reuters Health) – In a small study of rheumatoid arthritis patients, treatment with the anti-tumor necrosis factor (anti-TNF) agent infliximab appeared to increase the antioxidative capacity…
NEW YORK (Reuters Health) – Treatment with fenofibrate can reduce the risk of amputation in people with type 2 diabetes by 36%, according to a report in the…
